Sun Pharma Advanced Research Company Limited in UTI - Long Term Advantage Fund Series III · equitylore

Sun Pharma Advanced Research Company Limited · in UTI - Long Term Advantage Fund Series III

Sun Pharma Advanced Research Company Limited in UTI - Long Term Advantage Fund Series III

Held in 38 of the fund’s 62 disclosed months. Last held in Oct 2019.

Last weight

1.24%

₹3.3 Cr in Oct 2019

Weight over time

Share of the fund's portfolio each month. A gap is a month the fund disclosed without this stock.

Weight of Sun Pharma Advanced Research Company Limited in UTI - Long Term Advantage Fund Series III, Mar 2016 to Aug 2021.